Relationship between single nucleotide polymorphisms in −174G/C and −634C/G promoter region of interleukin-6 and prostate cancer

Abstract

The association between the single nucleotide polymorphisms (SNPs) in −174G/C and −634C/G of interleukin-6 (IL-6) promoter region and prostate cancer was examined in the population of Han people in Hubei region. TaqMan PCR was employed for the gene-typing of −174G/C and −634C/G in promoter region of IL-6 gene to compare the prostate cancer patients and normal controls in terms of genotype frequency, allele frequency and risk of prostate cancer. Enzyme-linked immunosorbent assay (ELISA) was used for the detection of IL-6 concentration in peripheral blood of the patients with prostate cancer and the relationship between the IL-6 level and the genotype was studied. Our results showed that in all the subjects, the genotype of genetic locus −174G/C was found to be GG and no CG and CC were observed. There was a significant difference in gene frequency of GG, CG and CC of −634C/G and allele frequency of G and C between prostate cancer patients and normal controls (P<0.05) and the gene frequency of GG+CG increased with the clinical stages and pathological grades of prostate cancer. The IL-6 level in GG+CG group was significantly higher than that in CC group. It was concluded that no SNP in −174G/C IL-6 promoter region was found in the population of Han people in Hubei region. The SNP in −634C/G was, to some extent, associated with the development and progression of prostate cancer. The population with GG+CG genetype has higher risk for prostate cancer.

Keywords

interleukin-6 / prostate cancer / single nucleotide polymorphisms / allele / genetype

References

[1] WalshP. C., RetikA. B., VaughanE. D., et al.Campbell’s urology, 20028PhiladelphiaSaunders

[2] JemalA., MurrayT., SamuelsA., et al.. Cancer statistics, 2003. CA Cancer J Clin, 2003, 53(1): 5-26

[3] HabuchiT.. Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model. Future Oncol, 2006, 2(2): 233-245

[4] SchneiderS., RoessliD., ExcoffierL.Arlequin, a software for population genetics data analysis. Ver2.000, 1997GenevaGenetics and Biometry Lab, Department of Anthropology, University of Geneva

[5] WilliamS., MarkS., JasbirS. S.. 1.9 Å crystal structure of interleukin-6: implications for a novel mode of receptor dimerization and signaling. EMBO, 1997, 16(5): 989-997

[6] AkiraS., TagaT., KishimotoT.. Interleukin-6 in biology and medicine. Adv Immunol, 1993, 54(1): 1-78

[7] DominiqueS. M., SarahE. D., SonjaI. B., et al.. Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res, 2006, 66(8): 4525-4530

[8] XuJ. F., JamesL., FredrikW., et al.. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 2005, 14(11): 4525-4530

[9] CoxE. D., HofferenceS. C., DimercurioB. S., et al.. Cytokine polymorphic analyses indicate ethnic difference in the allelic distribution of interlerkin-2 and interlerkin-6. Transp lantation, 2001, 72(4): 720-726

[10] ZhaiR., LiuG., YangC., et al.. The G to C polymorphism at −174 of the interleukin-6 gene is rare in a southern Chinese population. Pharmacogenetics, 2001, 11: 699-701

[11] LiuX. J., ChenX. M., SunX. F., et al.. Polymorphisms of interleukin-6 gene promoter region in healthy population in Beijing City of China: comparison with Asian descendants and Cancasian. Chin J Clin Rehabilitation (Chinese), 2005, 9(19): 116-118

[12] LimC. S., ZhengS., KimY. S., et al.. The −174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine, 2002, 19: 52-54

[13] McCarronS. L., EdwardsS., EvansP. R., et al.. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res, 2002, 62: 3369-3372

[14] KitamuraA., HasegawaG., ObayashiH., et al.. Interleukin-6 polymorphism (−634 C/G) in the promoter region and the progression of diabetic nephropathy in Type 2 diabetes. Diabetic Med, 2002, 19(12): 1000-1005